- Neuralstem (CUR +9%) FY14 results: Revenues: $0.02M (-80.0%); R&D Expense: $8.1M (+14.1%); SG&A: $9M (+69.8%); Operating Loss: ($17.4M) (-39.2%); Net Loss: ($22.6M) (-14.1%); Loss Per Share: ($0.26) (+3.7%); Quick Assets: $27.5M (+63.7%).
- No guidance given.
Neuralstem FY14 results
Recommended For You
More Trending News
About PALI Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PALI | - | - |
Palisade Bio, Inc. |